Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment
Clinical Translation and Interpretation of Current Evidence Clinical studies support the feasibility and general safety of several ischemic stroke cell-therapy platforms, but efficacy remains heterogeneous and cell therapy is not standard of care
2017 Apr 15 ;77(8):2064-2077
A clinical series published in the Journal of Clinical Medicine found that patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) who received intermittent intravenous saline infusions over a 9-week period showed beneficial effects in managing symptoms of dysautonomia and postural orthostatic tachycardia syndrome (POTS)
